HER2 alterations is associated with higher tumor mutation burden in gastric cancer

被引：0
|
作者：
Wei, B. [1 ]
Li, Z. [2 ]
Han, Q. [3 ]
Xing, X. [4 ]
Hao, Y. [5 ]
Zhou, J. [6 ]
Zhang, Y. [7 ]
Cai, S. [7 ]
Gu, Y. [8 ]
机构：
[1] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Gastrointestinal Surg, Guangzhou, Guangdong, Peoples R China
[2] Beijing Canc Hosp, Dept Gastrointestinal Surg, Beijing, Peoples R China
[3] Peoples Liberat Army 301 Hosp, Gen Hosp, Dept Oncol, Beijing, Peoples R China
[4] China Med Univ, Liaoning Canc Hosp & Inst, Dept Hematol & Breast Canc, Canc Hosp, Shenyang, Peoples R China
[5] Southwest Hosp, Dept Gen Surg, Chongqing, Peoples R China
[6] Peking Univ, Peoples Hosp, Gastrointestinal Surg, Beijing, Peoples R China
[7] 3D Med Co Ltd, Dept Med, Shanghai, Peoples R China
[8] Jiangsu Prov Hosp, Dept Oncol, Nanjing, Jiangsu, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
663P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Tumor mutation burden and immunogenicity in gastric cancer with HER2 alterations.
    Wei, Bo
    Xing, Xiaojing
    Li, Ziyu
    Han, Quanli
    Hao, Yingxue
    Zhou, Jing
    Zhang, Yuzi
    Zhao, Jing
    Cai, Shangli
    Gu, Yanhong
    Chen, Tufeng
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [2] HER2 amplification is associated with higher tumor mutation burden in breast cancer
    Yin, Y.
    Li, W.
    Huang, X.
    Wu, H.
    Zhang, Y.
    Cai, S.
    Zhou, S.
    ANNALS OF ONCOLOGY, 2018, 29
  • [3] HER2 polymorphism is associated with gastric cancer risk
    Pinto, D.
    Faustino, C.
    Ferreira, P.
    Teixeira, A. L.
    Pinto-Correia, A. L.
    Sousa, H.
    Dinis-Ribeiro, M.
    Fragoso, M.
    Medeiros, R.
    EJC SUPPLEMENTS, 2007, 5 (04): : 64 - 64
  • [4] Serum HER2 levels and HER2 status in tumor cells in advanced gastric cancer patients
    Sasaki, Takahide
    Fuse, Nozomu
    Kuwata, Takeshi
    Nomura, Shogo
    Kaneko, Kazuhiro
    Doi, Toshihiko
    Yoshino, Takayuki
    Asano, Hiromichi
    Ochiai, Atsushi
    Komatsu, Yoshito
    Sakamoto, Naoya
    Ohtsu, Atsushi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (01) : 43 - 48
  • [5] HER2 Testing in Gastric Cancer
    Albarello, Luca
    Pecciarini, Lorenza
    Doglioni, Claudio
    ADVANCES IN ANATOMIC PATHOLOGY, 2011, 18 (01) : 53 - 59
  • [6] HER2 in focus—gastric cancer
    Aysegül Ilhan-Mutlu
    memo - Magazine of European Medical Oncology, 2023, 16 : 217 - 217
  • [7] Her2 testing in gastric cancer
    Rueschoff, J.
    Nagelmeier, I.
    Baretton, G.
    Dietel, M.
    Hoefler, H.
    Schildhaus, H. U.
    Buettner, R.
    Schlake, W.
    Stoss, O.
    Kreipe, H. H.
    PATHOLOGE, 2010, 31 (03): : 208 - +
  • [8] SERUM HER2 IN GASTRIC CANCER
    Saito, M.
    Kaneto, H.
    Okuda, H.
    Kodaira, J.
    Hagiwara, T.
    Kozawa, H.
    Yoshimoto, M.
    Yamashita, K.
    Arimura, Y.
    Shinomura, Y.
    ANNALS OF ONCOLOGY, 2013, 24 : 33 - 33
  • [9] Tumor microenvironment immune types in gastric cancer are associated with mismatch repair however, not HER2 status
    Valentini, Anna Maria
    Di Pinto, Federica
    Coletta, Sergio
    Guerra, Vito
    Armentano, Raffaele
    Caruso, Maria Lucia
    ONCOLOGY LETTERS, 2019, 18 (02) : 1775 - 1785
  • [10] Association of HER2 gene amplification and tumor progression in early gastric cancer
    Kanayama, Kazuki
    Imai, Hiroshi
    Usugi, Eri
    Shiraishi, Taizo
    Hirokawa, Yoshifumi S.
    Watanabe, Masatoshi
    VIRCHOWS ARCHIV, 2018, 473 (05) : 559 - 565
12345